Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Kendrick

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
BMC Gastroenterology|March 28, 2013
White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkersTimothy Hardy, Christopher Wells, Stuart Kendrick, et al.
Gastro Hep Advances|August 12, 2024
Clinical Consequences of Hepatitis B Surface Antigen Loss in Chronic Hepatitis B Infection: A Systematic Literature Review and Meta-AnalysisEleonora Morais, Lauren Mason, John Dever, et al.
Alimentary Pharmacology & Therapeutics|September 19, 2018
Inequity of care provision and outcome disparity in autoimmune hepatitis in the United KingdomJessica K Dyson, Lin Lee Wong, Theophile Bigirumurame, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2018
Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United KingdomVinod S Hegade, George F Mells, Holly Fisher, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 9, 2019
Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritusVinod S Hegade, Alexandros Pechlivanis, Julie A K McDonald, et al.
Hepatology (Baltimore, Md.)|April 18, 2018
The Impact of Autoimmune Hepatitis and Its Treatment on Health UtilityLin Lee Wong, Holly F Fisher, Deborah D Stocken, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2022
GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Linerixibat in Primary Biliary Cholangitis Patients With PruritusCynthia Levy, Stuart Kendrick, Christopher L Bowlus, et al.
European Journal of Clinical Pharmacology|March 14, 2018
Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participantsCharlotte H Maden, David Fairman, Michelle Chalker, et al.
Journal of Hepatology|August 13, 2015
Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver diseaseCaroline L Wilson, Lindsay B Murphy, Jack Leslie, et al.
Drug Safety|February 14, 2024
Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory TherapyEric B Cohen, Arie Regev, Anju Garg, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
BMC Gastroenterology|March 28, 2013
White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkersTimothy Hardy, Christopher Wells, Stuart Kendrick, et al.
Gastro Hep Advances|August 12, 2024
Clinical Consequences of Hepatitis B Surface Antigen Loss in Chronic Hepatitis B Infection: A Systematic Literature Review and Meta-AnalysisEleonora Morais, Lauren Mason, John Dever, et al.
Alimentary Pharmacology & Therapeutics|September 19, 2018
Inequity of care provision and outcome disparity in autoimmune hepatitis in the United KingdomJessica K Dyson, Lin Lee Wong, Theophile Bigirumurame, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2018
Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United KingdomVinod S Hegade, George F Mells, Holly Fisher, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 9, 2019
Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritusVinod S Hegade, Alexandros Pechlivanis, Julie A K McDonald, et al.
Hepatology (Baltimore, Md.)|April 18, 2018
The Impact of Autoimmune Hepatitis and Its Treatment on Health UtilityLin Lee Wong, Holly F Fisher, Deborah D Stocken, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2022
GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Linerixibat in Primary Biliary Cholangitis Patients With PruritusCynthia Levy, Stuart Kendrick, Christopher L Bowlus, et al.
European Journal of Clinical Pharmacology|March 14, 2018
Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participantsCharlotte H Maden, David Fairman, Michelle Chalker, et al.
Journal of Hepatology|August 13, 2015
Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver diseaseCaroline L Wilson, Lindsay B Murphy, Jack Leslie, et al.
Drug Safety|February 14, 2024
Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory TherapyEric B Cohen, Arie Regev, Anju Garg, et al.
Pageof 4